689
Views
94
CrossRef citations to date
0
Altmetric
Review Article

Macaque cytochromes P450: nomenclature, transcript, gene, genomic structure, and function

, , &
Pages 346-361 | Received 18 Oct 2010, Accepted 15 Dec 2010, Published online: 09 Feb 2011

References

  • Baldwin, R. M., Jewell, W. T., Fanucchi, M. V., Plopper, C. G., Buckpitt, A. R. (2004). Comparison of pulmonary/nasal CYP2F expression levels in rodents and rhesus macaque. J Pharmacol Exp Ther 309:127–136.
  • Bellino, F. L., Wise, P. M. (2003). Nonhuman primate models of menopause workshop. Biol Reprod 68:10–18.
  • Bruford, E. A. (2010). Highlights of the “gene nomenclature across species” meeting. Hum Genomics 4:213–217.
  • Bullock, P., Pearce, R., Draper, A., Podval, J., Bracken, W., Veltman, J., et al. (1995). Induction of liver microsomal cytochrome P450 in cynomolgus monkeys. Drug Metab Dispos 23:736–748.
  • Carr, B., Norcross, R., Fang, Y., Lu, P., Rodrigues, A. D., Shou, M., et al. (2006). Characterization of the rhesus monkey CYP3A64 enzyme: species comparisons of CYP3A substrate specificity and kinetics using baculovirus-expressed recombinant enzymes. Drug Metab Dispos 34:1703–1712.
  • Domanski, T. L., Finta, C., Halpert, J. R., Zaphiropoulos, P. G. (2001). cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450. Mol Pharmacol 59:386–392.
  • Edwards, R. J., Murray, B. P., Murray, S., Schulz, T., Neubert, D., Gant, T. W., et al. (1994). Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and human. Carcinogenesis 15:829–836.
  • Ferguson, B., Street, S. L., Wright, H., Pearson, C., Jia, Y., Thompson, S. L., et al. (2007). Single nucleotide polymorphisms (SNPs) distinguish Indian-origin and Chinese-origin rhesus macaques (Macaca mulatta). BMC Genomics 8:43.
  • Gellner, K., Eiselt, R., Hustert, E., Arnold, H., Koch, I., Haberl, M., et al. (2001). Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. Pharmacogenetics 11:111–121.
  • Gerbal-Chaloin, S., Pascussi, J. M., Pichard-Garcia, L., Daujat, M., Waechter, F., Fabre, J. M., et al. (2001). Induction of CYP2C genes in human hepatocytes in primary culture. Drug Metab Dispos 29:242–251.
  • Hanioka, N., Yamamoto, M., Iwabu, H., Jinno, H., Tanaka-Kagawa, T., Naito, S., et al. (2007). Functional characterization of human and cynomolgus monkey cytochrome P450 2E1 enzymes. Life Sci 81:1436–1445.
  • Hashizume, T., Mise, M., Matsumoto, S., Terauchi, Y., Fujii, T., Imaoka, S., et al. (2001). A novel cytochrome P450 enzyme responsible for the metabolism of ebastine in monkey small intestine. Drug Metab Dispos 29:798–805.
  • Hernandez, R. D., Hubisz, M. J., Wheeler, D. A., Smith, D. G., Ferguson, B., Rogers, J., et al. (2007). Demographic histories and patterns of linkage disequilibrium in Chinese and Indian rhesus macaques. Science 316:240–243.
  • Hichiya, H., Kuramoto, S., Yamamoto, S., Shinoda, S., Hanioka, N., Narimatsu, S., et al. (2004). Cloning and functional expression of a novel marmoset cytochrome P450 2D enzyme, CYP2D30: comparison with the known marmoset CYP2D19. Biochem Pharmacol 68:165–175.
  • Hichiya, H., Takemi, C., Tsuzuki, D., Yamamoto, S., Asaoka, K., Suzuki, S., et al. (2002). Complementary DNA cloning and characterization of cytochrome P450 2D29 from Japanese monkey liver. Biochem Pharmacol 64:1101–1110.
  • Hoffman, S. M., Hu, S. (2007). Dynamic evolution of the CYP2ABFGST gene cluster in primates. Mutat Res 616:133–138.
  • Igarashi, T., Sakuma, T., Isogai, M., Nagata, R., Kamataki, T. (1997). Marmoset liver cytochrome P450s: study for expression and molecular cloning of their cDNAs. Arch Biochem Biophys 339:85–91.
  • Iwasaki, K., Uno, Y. (2009). Cynomolgus monkey CYPs: a comparison with human CYPs. Xenobiotica 39:578–581.
  • Kim, D., Guengerich, F. P. (2005). Cytochrome P450 activation of arylamines and heterocyclic amines. Annu Rev Pharmacol Toxicol 45:27–49.
  • Kim, S., Dinchuk, J. E., Anthony, M. N., Orcutt, T., Zoeckler, M. E., Sauer, M. B., et al. (2010). Evaluation of cynomolgus monkey pregnane X receptor, primary hepatocyte, and in vivo pharmacokinetic changes in predicting human CYP3A4 induction. Drug Metab Dispos 38:16–24.
  • Koch, I., Weil, R., Wolbold, R., Brockmöller, J., Hustert, E., Burk, O., et al. (2002). Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA. Drug Metab Dispos 30:1108–1114.
  • Komori, M., Kikuchi, O., Kitada, M., Kamataki, T. (1992a). Molecular cloning of monkey P450 1A1 cDNA and expression in yeast. Biochim Biophys Acta 1131:23–29.
  • Komori, M., Kikuchi, O., Sakuma, T., Funaki, J., Kitada, M., Kamataki, T. (1992b). Molecular cloning of monkey liver cytochrome P-450 cDNAs: similarity of the primary sequences to human cytochromes P-450. Biochim Biophys Acta 1171:141–146.
  • Lee, A. M., Joshi, M., Yue, J., Tyndale, R. F. (2006a). Phenobarbital induces monkey brain CYP2E1 protein but not hepatic CYP2E1, in vitro or in vivo chlorzoxazone metabolism. Eur J Pharmacol 552:151–158.
  • Lee, A. M., Miksys, S., Tyndale, R. F. (2006b). Phenobarbital increases monkey in vivo nicotine disposition and induces liver and brain CYP2B6 protein. Br J Pharmacol 148:786–794.
  • Lee, A. M., Yue, J., Tyndale, R. F. (2006c). In vivo and in vitro characterization of chlorzoxazone metabolism and hepatic CYP2E1 levels in African green monkeys: induction by chronic nicotine treatment. Drug Metab Dispos 34:1508–1515.
  • Lee, A. S., Gutiérrez-Arcelus, M., Perry, G. H., Vallender, E. J., Johnson, W. E., Miller, G. M., et al. (2008). Analysis of copy number variation in the rhesus macaque genome identifies candidate loci for evolutionary and human disease studies. Hum Mol Genet 17:1127–1136.
  • Mankowski, D. C., Laddison, K. J., Christopherson, P. A., Ekins, S., Tweedie, D. J., Lawton, M. P. (1999). Molecular cloning, expression, and characterization of CYP2D17 from cynomolgus monkey liver. Arch Biochem Biophys 372:189–196.
  • Matsunaga, T., Ohmori, S., Ishida, M., Sakamoto, Y., Nakasa, H., Kitada, M. (2002). Molecular cloning of monkey CYP2C43 cDNA and expression in yeast. Drug Metab Pharmacokinet 17:117–124.
  • Mitsuda, M., Iwasaki, M., Asahi, S. (2006). Cynomolgus monkey cytochrome P450 2C43: cDNA cloning, heterologous expression, purification, and characterization. J Biochem 139:865–872.
  • Narimatsu, S., Oda, M., Hichiya, H., Isobe, T., Asaoka, K., Hanioka, N., et al. (2005). Molecular cloning and functional analysis of cytochrome P450 1A2 from Japanese monkey liver: comparison with marmoset cytochrome P450 1A2. Chem Biol Interact 152:1–12.
  • Narimatsu, S., Torigoe, F., Tsuneto, Y., Saito, K., Hanioka, N., Masuda, K., et al. (2006). Cloning of a cDNA encoding a novel marmoset CYP2C enzyme, expression in yeast cells, and characterization of its enzymatic functions. Biochem Pharmacol 72:1738–1748.
  • Nelson, D. R., Zeldin, D. C., Hoffman, S. M., Maltais, L. J., Wain, H. M., Nebert, D. W. (2004). Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes, and alternative-splice variants. Pharmacogenetics 14:1–18.
  • Nishimura, M., Koeda, A., Suganuma, Y., Suzuki, E., Shimizu, T., Nakayama, M, et al. (2007). Comparison of inducibility of CYP1A and CYP3A mRNAs by prototypical inducers in primary cultures of human, cynomolgus monkey, and rat hepatocytes. Drug Metab Pharmacokinet 22:178–186.
  • Ohmori, S., Sakamoto, Y., Nakasa, H., Kitada, M. (1998). Nucleotide and amino acid sequences of the monkey P450 2B gene subfamily. Res Commun Mol Pathol Pharmacol 99:17–22.
  • Ohmori, S., Shirakawa, C., Motohashi, K., Yoshida, H., Abe, H., Nakamura, T., et al. (1993). Purification from liver microsomes from untreated cynomolgus monkeys of cytochrome P450 closely related to human cytochrome P450 2B6. Mol Pharmacol 43:183–190.
  • Ohtsuka, T., Yoshikawa, T., Kozakai, K., Tsuneto, Y., Uno, Y., Utoh, M., et al. (2010). Alprazolam as an in vivo probe for studying induction of CYP3A in cynomolgus monkeys. Drug Metab Dispos 38:1806–1813.
  • Prueksaritanont, T., Kuo, Y., Tang, C., Li, C., Qiu, Y., Lu, B., et al. (2006). In vitro and in vivo CYP3A64 induction and inhibition studies in rhesus monkeys: a preclinical approach for CYP3A-mediated drug interaction studies. Drug Metab Dispos 34:1546–1555.
  • Qiu, H., Taudien, S., Herlyn, H., Schmitz, J., Zhou, Y., Chen, G., et al. (2008). CYP3 phylogenomics: evidence for positive selection of CYP3A4 and CYP3A7. Pharmacogenet Genomics 18:53–66.
  • Quattrochi, L. C., Tukey, R. H. (1993). Nuclear uptake of the Ah (dioxin) receptor in response to omeprazole: transcriptional activation of the human CYP1A1 gene. Mol Pharmacol 43:504–508.
  • Roth, G. S., Mattison, J. A., Ottinger, M. A., Chachich, M. E., Lane, M. A., Ingram, D. K. (2004). Aging in rhesus monkeys: relevance to human health interventions. Science 305:1423–1426.
  • Sakuma, T., Hieda, M., Igarashi, T., Ohgiya, S., Nagata, R., Nemoto, N., et al. (1998). Molecular cloning and functional analysis of cynomolgus monkey CYP1A2. Biochem Pharmacol 56:131–139.
  • Sakuma, T., Igarashi, T., Hieda, M., Ohgiya, S., Isogai, M., Ninomiya, S., et al. (1997). Marmoset CYP1A2: primary structure and constitutive expression in livers. Carcinogenesis 18:1985–1991.
  • Schoedel, K. A., Sellers, E. M., Palmour, R., Tyndale, R. F. (2003). Down-regulation of hepatic nicotine metabolism and a CYP2A6-like enzyme in African green monkeys after long-term nicotine administration. Mol Pharmacol 63:96–104.
  • Schulz, T. G., Thiel, R., Davies, D. S., Edwards, R. J. (1998). Identification of CYP2E1 in marmoset monkey. Biochim Biophys Acta 1382:287–294.
  • Schulz, T. G., Thiel, R., Neubert, D., Brassil, P. J., Schulz-Utermoehl, T., et al. (2001). Assessment of P450 induction in the marmoset monkey using targeted anti-peptide antibodies. Biochim Biophys Acta 1546:143–155.
  • Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., Guengerich, F. P. (1994). Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens, and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414–423.
  • Street, S. L., Kyes, R. C., Grant, R., Ferguson, B. (2007). Single nucleotide polymorphisms (SNPs) are highly conserved in rhesus (Macaca mulatta) and cynomolgus (Macaca fascicularis) macaques. BMC Genomics 8:480.
  • Takagi, Y., Takahashi, J., Saiki, H., Morizane, A., Hayashi, T., Kishi, Y., et al. (2005). Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J Clin Invest 115:102–109.
  • Tang et al. (2008). CYP2C75-involved autoinduction of metabolism in rhesus monkeys of methyl 3-chloro-3′-fluoro-4′-{(1R)-1-[({1-[(trifluoroacetyl)amino]cyclopropyl}carbonyl)amino]ethyl}-1,1′-biphenyl-2-carboxylate (MK-0686), a bradykinin B1 receptor antagonist. J Pharmacol Exp Ther 325:935–946.
  • Tang, C., Fang, Y., Booth-Genthe, C., Kuo, Y., Kuduk, S. D., Rushmore, T. H., et al. (2007). Diclofenac hydroxylation in monkeys: efficiency, regioselectivity, and response to inhibitors. Biochem Pharmacol 73:880–890.
  • Uehara, S., Murayama, N., Yamazaki, H., Uno, Y. (2010). A novel CYP2A26 identified in cynomolgus monkey liver metabolizes coumarin. Xenobiotica 40:621–629.
  • Uno, Y., Fujino, H., Iwasaki, K., Utoh, M. (2010a). Macaque CYP2C76 encodes cytochrome P450 enzyme not orthologous to any human isozymes. Curr Drug Metab 11:142–152.
  • Uno, Y., Fujino, H., Kito, G., Kamataki, T., Nagata, R. (2006). CYP2C76, a novel cytochrome P450 in cynomolgus monkey, is a major CYP2C in liver, metabolizing tolbutamide and testosterone. Mol Pharmacol 70:477–486.
  • Uno, Y., Hosaka, S., Matsuno, K., Nakamura, C., Kito, G., Kamataki, T., et al. (2007a). Characterization of cynomolgus monkey cytochrome P450 (CYP) cDNAs: Is CYP2C76 the only monkey-specific CYP gene responsible for species differences in drug metabolism? Arch Biochem Biophys 466:98–105.
  • Uno, Y., Kumano, T., Kito, G., Nagata, R., Kamataki, T., Fujino, H. (2007b). CYP2C76-mediated species difference in drug metabolism: A comparison of pitavastatin metabolism between monkeys and humans. Xenobiotica 37:30–43.
  • Uno, Y., Matsuno, K., Nakamura, C., Utoh, M., Yamazaki, H. (2009a). Cloning, expression, and characterization of CYP3A43 cDNA in cynomolgus macaque (Macaca fascicularis). Drug Metab Lett 3:228–233.
  • Uno, Y., Matsuno, K., Nakamura, C., Utoh, M., Yamazaki, H. (2009b). Identification and characterization of CYP2B6 cDNA in cynomolgus macaques (Macaca fascicularis). J Vet Med Sci 71:1653–1656.
  • Uno, Y., Matsuno, K., Nakamura, C., Utoh, M., Yamazaki, H. (2010b). Identification and characterization of CYP2C18 in the cynomolgus macaque (Macaca fascicularis). J Vet Med Sci 72:225–228.
  • Uno, Y., Matsushita, A., Osada, N., Uehara, S., Kohara, S., Nagata, R., et al. (2010c). Genetic variants of CYP3A4 and CYP3A5 in cynomolgus and rhesus macaques. Drug Metab Dispos 38:209–214.
  • Uno, Y., Sakuraba, H., Uehara, S., Kumano, T., Matsuno, K., Nakamura, C., et al. (2009c). A null allele impairs function of CYP2C76 gene in cynomolgus monkeys: a possible genetic tool for generation of a better animal model in drug metabolism. Drug Metab Dispos 37:14–17.
  • Uno, Y., Suzuki, Y., Wakaguri, H., Sakamoto, Y., Sano, H., Osada, N., et al. (2008). Expressed sequence tags from cynomolgus monkey (Macaca fascicularis) liver: A systematic identification of drug-metabolizing enzymes. FEBS Lett 582:351–358.
  • Uno, Y., Uehara, S., Kohara, S., Murayama, N., Yamazaki, H. (2010d). Cynomolgus monkey CYP2D44, newly identified in liver, metabolizes bufuralol and dextromethorphan. Drug Metab Dispos 38:1486–1492.
  • Weaver, R. J., Dickins, M., Burke, M. D. (1999). A comparison of basal and induced hepatic microsomal cytochrome P450 monooxygenase activities in the cynomolgus monkey (Macaca fascicularis) and man. Xenobiotica 29:467–482.
  • Westlind-Johnsson, A., Malmebo, S., Johansson, A., Otter, C., Andersson, T. B., Johansson, I., et al. (2003). Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism. Drug Metab Dispos 31:755–761.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.